Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MDA (Medical Devices Agency) gives strong advice on clinical trials

This article was originally published in Clinica

Executive Summary

The UK's Medical Devices Agency raises objections to some 20% of clinical investigations each year. It is viewed as a particularly strict authority. But the MDA remains committed to continuing its policy since many serious problems with devices in the marketplace can be traced back to inadequate clinical investigation data, Susanne Ludgate, medical director, said at the recent MDA meeting* in London.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT072209

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel